Prognostic Predictive Characteristics in Patients With Fibrosing Interstitial Lung Disease: A Retrospective Cohort Study.

Front Pharmacol · 2022 · PMC9283576 · PMID 35847019

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Our data showed a trend of better survival in patients with PF-ILD, though not statistically significant, who received anti-fibrotic treatment; nintedanib and pirfenidone are known to prolong life expectancy in patients with IPF ( Costabel et al., 2017 ; Lancaster et al., 2019 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.